Delivery Order SPE2DB22D2211-SPE2DB25FRYFJ
- Not listed
- The Defense Logistics Agency awarded a $1,086.88 delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials under a firm fixed price contract type. The award was issued on July 11, 2025, with an ultimate completion date of July 14, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is a child contract under...
- The Defense Logistics Agency Medical Supply Chain awarded a $7,301.66 delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials, with an ultimate completion date of August 13, 2025. This competitive award represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems through its...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ketorolac 30 mg/mL vials with a ceiling value of $1,002.57. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $1,194.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ketorolac 30 mg/ml vials. The contract is a non-set-aside competitive award with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Department's Medical Supply Chain has awarded a $6,176.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. The contract was competitively awarded without set-aside provisions on August 18, 2025, with an ultimate completion date of August 19, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...
- The Defense Logistics Agency has awarded a delivery order valued at $2,909.40 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. This competitive award, issued on August 19, 2025, represents a firm fixed price delivery order with an ultimate completion date of August 20, 2025. The pharmaceutical distributor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's larger...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for Ketorolac 30 mg/mL vials with a ceiling value of $2,472.26. This firm fixed-price delivery order represents a non-competitive set-aside contract and carries an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,250.60 to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials, with completion scheduled for August 19, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement typical of pharmaceutical supply orders under the DLA's medical procurement framework. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,427.96 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. This contract, awarded on August 28, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively procured through open...
- The Defense Logistics Agency awarded a $2,424.50 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ketorolac 30 mg/mL vials. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The contract was competitively awarded with no set-aside designation, and performance will be fulfilled from...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FRYFJDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,616.58 to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials, with an ultimate completion date of June 3, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX. This prime IDV, valued at $999,999,999.00 and extending through December 2026, serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling delivery orders for diverse pharmaceutical products including specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Ketorolac, a nonsteroidal anti-inflammatory pain management medication, exemplifies the company's role in supplying essential pharmaceutical commodities to support Defense Health Agency operations and broader military healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 6/2/25 |